Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
41,560,365
-
Share change
-
-93,205
-
Total reported value
-
$219,855,933
-
Price per share
-
$5.29
-
Number of holders
-
78
-
Value change
-
-$178,331
-
Number of buys
-
38
-
Number of sells
-
37
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2019
As of 31 Dec 2019,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,560,365 shares.
The largest 10 holders included
NEA Management Company, LLC, BVF INC/IL, Invesco Ltd., WELLINGTON MANAGEMENT GROUP LLP, Camber Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, DIMENSIONAL FUND ADVISORS LP, and AXA.
This page lists
78
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.